Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 1990 Apr;34(4):499-504.

    Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia.

    Source

    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

    Abstract

    In summary, recent advances in our ability to diagnose, treat, and prevent recurrences of pneumocystis pneumonia have significantly improved the clinical management of this infection, especially in HIV-1-infected individuals. As current investigations allow our therapeutic armamentarium in this disease to be strengthened even further, it is likely that pneumocystis pneumonia will pose a diminishing threat to those patients currently most susceptible to this infection.

    PMID:
    2140495
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC171632
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk